These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7152739)

  • 1. Methods for evaluating optimal dosage regimens and their application to theophylline.
    Richter O; Reinhardt D
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):564-75. PubMed ID: 7152739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Developing a dose-administration schedule for drug therapy in childhood].
    Richter O; Reinhardt D; Stutzinger W
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):63-5. PubMed ID: 6843558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rabbit as an experimental model for biopharmaceutical studies following rectal administration of theophylline.
    Van Aerde P; Moerman E; Van Severen R; Braeckman P
    Pharmazie; 1984 Mar; 39(3):171-2. PubMed ID: 6728890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics in drug therapy II: Applications of clinical pharmacokinetics in the assessment of theophylline therapy.
    Floyd RA; Cohen JL
    Am J Hosp Pharm; 1977 Apr; 34(4):402-7. PubMed ID: 871124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining chronic oral dosage regimens for theophylline.
    Kendall JD
    Am J Hosp Pharm; 1979 Jun; 36(6):744-5. PubMed ID: 463888
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term treatment of sleep apnea with evening administration of oral retard theophylline].
    Dorow P; Thalhofer S; Heinemann S; Meissner P; Kühler U
    Pneumologie; 1993 Dec; 47 Suppl 4():778-9. PubMed ID: 8153109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of two dosing equations for theophylline in premature infants.
    Bhatt-Mehta V; Donn SM; Schork MA; Reed S; Johnson CE
    Pharmacotherapy; 1996; 16(5):769-76. PubMed ID: 8888073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin.
    Schumacher GE
    Am J Hosp Pharm; 1980 Jan; 37(1):128-32. PubMed ID: 7361770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-order versus zero-order absorption models for predicting theophylline concentrations after conversion from intravenous to oral therapy.
    Kehoe WA; Williams PJ; Brown JF
    Clin Pharm; 1990 Jun; 9(6):458-61. PubMed ID: 2364650
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.
    Loughnan PM; Sitar DS; Ogilvie RI; Eisen A; Fox Z; Neims AH
    J Pediatr; 1976 May; 88(5):874-9. PubMed ID: 1271155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.
    Brouwers J; Ingels F; Tack J; Augustijns P
    J Pharm Pharmacol; 2005 Aug; 57(8):987-96. PubMed ID: 16102254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C; Niggemann B; Wahn U
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of theophylline dosage regimens from limited serum sampling.
    Robinson JD; Boysen PG; Lupkiewicz SM; Krischer JP; Ariet M
    Drug Intell Clin Pharm; 1982 Oct; 16(10):752-8. PubMed ID: 6897223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent versus first-order kinetics in theophylline elimination.
    Weinberger M
    Am J Hosp Pharm; 1979 Apr; 36(4):452-3. PubMed ID: 433933
    [No Abstract]   [Full Text] [Related]  

  • 20. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.